Pharmaphobia

How the Conflict of Interest Myth Undermines American Medical Innovation

Nonfiction, Health & Well Being, Medical, Reference, Health Policy, Health, Health Care Issues
Cover of the book Pharmaphobia by Thomas P. Stossel, Rowman & Littlefield Publishers
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Thomas P. Stossel ISBN: 9781442244634
Publisher: Rowman & Littlefield Publishers Publication: April 23, 2015
Imprint: Rowman & Littlefield Publishers Language: English
Author: Thomas P. Stossel
ISBN: 9781442244634
Publisher: Rowman & Littlefield Publishers
Publication: April 23, 2015
Imprint: Rowman & Littlefield Publishers
Language: English

For millennia, human survival depended on our innate abilities to fight pathogens and repair injuries. Only recently has medical science prolonged longevity and improved quality of life. Physicians and academic researchers contribute to such progress, but the principal contributor is private industry that produces the tools – drugs and medical devices – enabling doctors to prevent and cure disease. Heavy regulation and biology’s complexity and unpredictability make medical innovation extremely difficult and expensive.

Pharmaphobia describes how an ideological crusade, stretching over the last quarter century, has used distortion and flawed logic to make medical innovation even harder in a misguided pursuit of theoretical professional purity. Bureaucrats, reporters, politicians, and predatory lawyers have built careers attacking the medical products industry, belittling its critical contributions to medical innovation and accusing it of non-existent malfeasance: overselling product value, flaunting safety and corrupting physicians and academics who partner with it. The mania has imposed “conflict-of-interest” regulations limiting or banning valuable interactions between industry and physicians and researchers and diverting scarce resources from innovation to compliance. The victims are patients suffering from cancer, dementia, and other serious diseases for which new treatments are delayed, reduced, or eliminated as a result of these pointless regulations. With breathtaking detail, Thomas Stossel shows how this attack on doctors who work with industry limits medical innovation and inhibits the process of bringing new products into medical care.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

For millennia, human survival depended on our innate abilities to fight pathogens and repair injuries. Only recently has medical science prolonged longevity and improved quality of life. Physicians and academic researchers contribute to such progress, but the principal contributor is private industry that produces the tools – drugs and medical devices – enabling doctors to prevent and cure disease. Heavy regulation and biology’s complexity and unpredictability make medical innovation extremely difficult and expensive.

Pharmaphobia describes how an ideological crusade, stretching over the last quarter century, has used distortion and flawed logic to make medical innovation even harder in a misguided pursuit of theoretical professional purity. Bureaucrats, reporters, politicians, and predatory lawyers have built careers attacking the medical products industry, belittling its critical contributions to medical innovation and accusing it of non-existent malfeasance: overselling product value, flaunting safety and corrupting physicians and academics who partner with it. The mania has imposed “conflict-of-interest” regulations limiting or banning valuable interactions between industry and physicians and researchers and diverting scarce resources from innovation to compliance. The victims are patients suffering from cancer, dementia, and other serious diseases for which new treatments are delayed, reduced, or eliminated as a result of these pointless regulations. With breathtaking detail, Thomas Stossel shows how this attack on doctors who work with industry limits medical innovation and inhibits the process of bringing new products into medical care.

More books from Rowman & Littlefield Publishers

Cover of the book Assessment, Bureaucracy, and Consolidation by Thomas P. Stossel
Cover of the book Representing 9/11 by Thomas P. Stossel
Cover of the book Public Matters by Thomas P. Stossel
Cover of the book Rehearsing by Thomas P. Stossel
Cover of the book Dangerous Women by Thomas P. Stossel
Cover of the book The Complete Book of 1990s Broadway Musicals by Thomas P. Stossel
Cover of the book From Floundering to Fluent by Thomas P. Stossel
Cover of the book Five Challenges for the Once and Future Church by Thomas P. Stossel
Cover of the book Making Autism a Gift by Thomas P. Stossel
Cover of the book Why States Matter by Thomas P. Stossel
Cover of the book The Francis Effect by Thomas P. Stossel
Cover of the book Jews in the Early Modern World by Thomas P. Stossel
Cover of the book The Adaptive School by Thomas P. Stossel
Cover of the book The Laughing Dead by Thomas P. Stossel
Cover of the book User Friendly Evaluation by Thomas P. Stossel
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy